Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neuromodulatory Effect of Combined Transcranial Direct Current Stimulation with Intensive Aphasia Therapy in the Chronic Phase After Stroke

NCT03305614 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03305614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03305614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neuromodulatory Effect of Combined Transcranial Direct Current Stimulation with Intensive Aphasia Therapy in the Chronic Phase After Stroke
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Terminated
Start date
November 24, 2017
Completion date
April 18, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia following cerebral infarction, aphasia following nontraumatic intracerebral hemorrhage